Retrospective analysis of The Two Sister Study using haplotype-based association testing to identify loci associated with early-onset breast cancer - Gilbert, James R.; Cray, James J.; Losee, Joseph E.; Cooper, Gregory M. (medRxiv, 2020)
Breast cancer is a polygenic disorder and is the leading cause of cancer related mortality among women. Early-onset breast cancer (EOBC) is diagnosed in women prior to 45 years-of-age and is associated with worse clinical outcomes, a more aggressive disease phenotype, and poor prognosis for disease-free survival. While substantial progress has been made in defining the genetics of breast cancer, EOBC remains less well understood. In the current study we perform a retrospective analysis of data derived from The Two Sister Study. The use of alternate strategies for handling age-at-diagnosis in conjunction with haplotype-based methods yielded novel findings that help to explain the heritability of EOBC. These findings are validated through comparison against discordant sibs from The Two Sister Study as well as using data derived The Cancer Genome Atlas (TCGA).Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding: The work described within this study was funded through the Childrens Fund of Childrens Hospital of Pittsburgh of UPMC and through the Ross H. Musgrave Endowment (J.E.L).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data evaluated within this study is primarily obtained through dbGAP. Controlled access was obtained through the University of Pittsburgh IRB and was approved for research use through a Data Use Agreement via dbGAP.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPertinent data may be accessed through dbGAP. The Two Sister Study: A Family-Based Study of Genes and Environment in Young-Onset Breast Cancer (accession phs000678.v1.p1). All other data sources including but not limited to cbioportal, 1000 Genomes, and The Cancer Genome Atlas are within the public domain and may be freely accoessed using public data portals. https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000678.v1.p1